Palvella Therapeutics宣布任命经验丰富的科学家兼生物制药行业高管David W. Osborne博士担任首席创新官,以此举措进一步加强公司领导层实力。
Palvella Therapeutics宣布任命经验丰富的科学家兼生物制药行业高管David W. Osborne博士担任首席创新官,以此举措进一步加强公司领导层实力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.